29 related articles for article (PubMed ID: 38615488)
1. Chimeric Peptide-Engineered Self-Delivery Nanomedicine for Photodynamic-Triggered Breast Cancer Immunotherapy by Macrophage Polarization.
Liu YB; Chen XY; Yu BX; Cen Y; Huang CY; Yan MY; Liu QQ; Zhang W; Li SY; Tang YZ
Small; 2024 May; 20(22):e2309994. PubMed ID: 38095445
[TBL] [Abstract][Full Text] [Related]
2. Supramolecular Peptide Amphiphile Nanospheres Reprogram Tumor-associated Macrophage to Reshape the Immune Microenvironment for Enhanced Breast Cancer Immunotherapy.
Xiao Q; Huang J; Wang X; Chen Z; Zhang W; Liu F; Li J; Yang Z; Zhan J; Cai Y
Small; 2024 May; 20(21):e2307390. PubMed ID: 38100300
[TBL] [Abstract][Full Text] [Related]
3. Polyporus umbellatus polysaccharide iron-based nanocomposite for synergistic M1 polarization of TAMs and combinational anti-breast cancer therapy.
Liu T; Han T; Liu C; Ge C; Jiang X; Liu Y; Kong F; Su X; Shi J; Su W; Li X; Chen Y; Zhang H; Ma Q; Qu D
Int J Biol Macromol; 2023 Nov; 251():126323. PubMed ID: 37586629
[TBL] [Abstract][Full Text] [Related]
4. CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression.
Zhang M; Liu ZZ; Aoshima K; Cai WL; Sun H; Xu T; Zhang Y; An Y; Chen JF; Chan LH; Aoshima A; Lang SM; Tang Z; Che X; Li Y; Rutter SJ; Bossuyt V; Chen X; Morrow JS; Pusztai L; Rimm DL; Yin M; Yan Q
Sci Transl Med; 2022 Feb; 14(630):eabf5473. PubMed ID: 35108062
[TBL] [Abstract][Full Text] [Related]
5. Baohuoside i suppresses breast cancer metastasis by downregulating the tumor-associated macrophages/C-X-C motif chemokine ligand 1 pathway.
Wang S; Wang N; Huang X; Yang B; Zheng Y; Zhang J; Wang X; Lin Y; Wang Z
Phytomedicine; 2020 Nov; 78():153331. PubMed ID: 32911383
[TBL] [Abstract][Full Text] [Related]
6. TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
Lee C; Kim S; Jeong C; Cho I; Jo J; Han IH; Bae H
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216272
[TBL] [Abstract][Full Text] [Related]
7. Targeting Pro-Tumoral Macrophages in Early Primary and Metastatic Breast Tumors with the CD206-Binding mUNO Peptide.
Lepland A; Asciutto EK; Malfanti A; Simón-Gracia L; Sidorenko V; Vicent MJ; Teesalu T; Scodeller P
Mol Pharm; 2020 Jul; 17(7):2518-2531. PubMed ID: 32421341
[TBL] [Abstract][Full Text] [Related]
8. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567
[TBL] [Abstract][Full Text] [Related]
9. Optical controlled and nuclear targeted CECR2 competitor to downregulate CSF-1 for metastatic breast cancer immunotherapy.
Cen Y; Chen Y; Li X; Chen X; Yu B; Yan M; Yan N; Cheng H; Li S
Biomaterials; 2024 Jul; 308():122568. PubMed ID: 38615488
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.
Xiao M; He J; Yin L; Chen X; Zu X; Shen Y
Front Immunol; 2021; 12():799428. PubMed ID: 34992609
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
[TBL] [Abstract][Full Text] [Related]
12. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
